Deep Brain Stimulation Devices Market Size, Share | 2032

Report Description

Deep Brain Stimulation Devices Market Outlook 2032

The global deep brain stimulation devices market size was USD 1.30 Billion in 2023 and is projected to reach USD 3.12 Billion by 2032, expanding at a CAGR of 10.2% during 2024–2032. The market growth is attributed to the increasing adoption of deep brain stimulation (DBS) devices across a wide range of neurological and psychiatric disorders.

Increasing awareness and expanding applications across diverse sectors of DBS devices are boosting the market. These devices are important in therapeutic modalities to improve patient's quality of life. Moreover, healthcare providers seek innovative treatment solutions to treat the growing burden of Parkinsons and neurological issues, which further propels the market.

• According to a report by the National Institutes of Health in November 2023, neurological disorders resulted in 97.72 million disability-adjusted life-years (DALYs) in 2019, causing an age-standardized DALY rate of 1253.56 per 100,000 population.\\
  

  Get Free Sample Report
  

Impact of Artificial Intelligence (AI) in Deep Brain Stimulation Devices Market

The use of artificial intelligence is likely to boost the deep brain stimulation devices market. AI-powered imaging techniques, such as functional MRI (fMRI) and diffusion tensor imaging (DTI) are enhancing the accuracy and effectiveness of DBS therapy. Additionally, AI-driven robotics assist neurosurgeons in performing minimally invasive DBS procedures with enhanced precision and safety.

Deep Brain Stimulation Devices Market Dynamics

Get Free Sample Report

Major Drivers

Growing geriatric population worldwide is anticipated to drive the market during the forecast period. The prevalence of age-related neurological conditions, such as Parkinson’s disease and essential tremor are increasing. Elderly individuals are prone to developing these disorders, leading to a high demand for effective treatment options, including DBS therapy. Additionally, advancements in healthcare infrastructure and access to medical facilities in emerging economies are contributing to fueling the market.

• According to the report published by the WHO on August 9, 2023, states that in 2019 there were over 8.5 million PD cases worldwide.

Existing Restraints

High cost associated with DBS therapy is expected to hinder the market. The procedure involves surgical implantation of electrodes and pulse generators, and with subsequent programming and follow-up visits which contribute to the overall cost. Moreover, the limited availability of skilled healthcare professionals trained in DBS therapy is expected to hinder the market during the forecast period.

Emerging Opportunities

­Ongoing R&D activities are expected to create immense opportunities for the players competing in the market. Manufacturers are actively exploring new developments in next-generation DBS devices with improved targeting, stimulation parameters, and closed-loop systems. Furthermore, collaborative efforts between academic institutions, medical device companies, and government organizations are fostering innovation in DBS technology, thereby boosting the market.

Scope of the Deep Brain Stimulation Devices Market Report

The market report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics are included in the report.

Deep Brain Stimulation Devices Market Segment Insights

Product Segment Analysis

Based on product, the deep brain stimulation devices market is divided into single-channel and dual-channel. The dual-channel segment is expected to expand at a significant pace in the coming years, owing to its higher efficacy and flexibility than single channel counterparts.

Dual-channel DBS devices enable simultaneous stimulation of multiple brain regions or targets for precise and personalized treatment approaches. Moreover, healthcare providers are using dual-channel DBS therapy to improve patient outcomes and reduce the overall burden of neurological disorders, which further fuels the segment.

Get Free Sample Report

Application Segment Analysis

On the basis of application, the global market is segregated into Parkinson’s disease, essential tremor, dystonia, and others. The Parkinson’s disease segment held the largest market share in 2023, due to the high utilization of deep brain stimulation therapy for its efficacy in managing symptoms.

DBS therapy has emerged as a highly effective treatment option for Parkinson’s patients, particularly those experiencing motor fluctuations and medication-related side effects. Moreover, the growing number of patients suffering from Parkinson’s disease boosts the market.

The essential tremor segment is anticipated to expand at a substantial CAGR during the forecast period, owing to the high risks of these types of tumors causing disability and impairment. DBS therapy has demonstrated remarkable efficacy in reducing tremor severity and improving functional outcomes for essential tremor patient’s refractory to medication. Furthermore, the advancements in DBS technology and expanding access to specialized cancer cure treatment propels the market during the forecast period.

End-user Segment Analysis

Based on end-user, the deep brain stimulation devices market is segmented into hospitals, clinics, research institutes, and others. The clinics segment is projected to register a robust growth during the assessment years, owing to the increasing preference for outpatient procedures and minimally invasive surgical techniques.

Clinics offer a streamlined and patient-centered approach to DBS therapy, with dedicated neurology and neurosurgery teams focused on providing personalized care and optimizing treatment outcomes. Moreover, DBS clinics often leverage advanced imaging technologies, such as MRI and CT scans, for precise targeting and electrode placement during DBS procedures, which further boosts the segment.

Get Free Sample Report

Regional Outlook

In terms of region, the global deep brain stimulation devices market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America held a major market share in 2023, due to the high prevalence rate of neurological disorders. For instance, as per the report by the Pan American Health Organization, neurological conditions caused 533,172 deaths in 2019. Of these deaths, 40% were in men (213,129) and 60% were in women (320,043). Moreover, the presence of leading manufacturers and research institutions in the region fosters innovation and development in DBS technologies, which is booting the market.

The market in Asia Pacific is projected to grow at a significant pace in the coming years, owing to rising healthcare expenditure and expanding access to advanced medical technologies. Countries, such as China, India, and Japan, are focusing on developing effective healthcare infrastructures to cater to the growing aged populations. Furthermore, the increasing rates of various neurological disorders are likely to propel the market during the forecast period.

Get Free Sample Report